Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026)
Personalis (PSNL) posted quarterly Total Non-Current Liabilities of $70.1 million for Q1 2026, up 9.47% year-over-year from $64.0 million in Q1 2025, and down 2.0% on a QoQ basis from $71.5 million in Q4 2025.
Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Personalis (PSNL) has reported Total Non-Current Liabilities for 9 consecutive years, with $70.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 9.47% year-over-year to $70.1 million; the TTM figure through Mar 2026 stood at $70.1 million (up 9.47% YoY), while the FY2025 annual figure was $71.5 million, up 8.31% from the prior year.
- Total Non-Current Liabilities came in at $70.1 million for Q1 2026 at Personalis, down from $71.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $93.3 million in Q2 2022, with the low at $64.0 million in Q1 2025.
- Average Total Non-Current Liabilities over 5 years is $74.2 million, with a median of $71.6 million recorded in 2023.
- Across the five-year window, Total Non-Current Liabilities surged 119.09% in 2022 and retreated 27.06% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $74.2 million in 2022, then grew by 22.01% to $90.5 million in 2023, then declined by 27.06% to $66.0 million in 2024, then increased by 8.31% to $71.5 million in 2025, then declined by 2.0% to $70.1 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $70.1 million, $71.5 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Personalis | 1.44 Bn | 1.20 Bn | 281,000.00 | 70.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.07 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 68.81 Mn |
| Jun 30, 2025 | 65.11 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 66.01 Mn |
| Sep 30, 2024 | 72.01 Mn |
| Jun 30, 2024 | 72.17 Mn |
| Mar 31, 2024 | 71.56 Mn |
| Dec 31, 2023 | 90.50 Mn |
| Sep 30, 2023 | 71.64 Mn |
| Jun 30, 2023 | 68.92 Mn |
| Mar 31, 2023 | 74.45 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 75.09 Mn |
| Jun 30, 2022 | 93.34 Mn |
| Mar 31, 2022 | 92.21 Mn |
| Dec 31, 2021 | 84.11 Mn |
| Sep 30, 2021 | 79.38 Mn |
| Jun 30, 2021 | 42.61 Mn |